These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Treatment of true precocious puberty with a potent luteinizing hormone-releasing factor agonist: effect on growth, sexual maturation, pelvic sonography, and the hypothalamic-pituitary-gonadal axis. Styne DM, Harris DA, Egli CA, Conte FA, Kaplan SL, Rivier J, Vale W, Grumbach MM. J Clin Endocrinol Metab; 1985 Jul; 61(1):142-51. PubMed ID: 3923027 [Abstract] [Full Text] [Related]
8. Long term treatment of male and female precocious puberty by periodic administration of a long-acting preparation of D-Trp6-luteinizing hormone-releasing hormone microcapsules. Roger M, Chaussain JL, Berlier P, Bost M, Canlorbe P, Colle M, Francois R, Garandeau P, Lahlou N, Morel Y. J Clin Endocrinol Metab; 1986 Apr; 62(4):670-7. PubMed ID: 2936759 [Abstract] [Full Text] [Related]
9. Variable response to a long-acting agonist of luteinizing hormone-releasing hormone in girls with McCune-Albright syndrome. Foster CM, Comite F, Pescovitz OH, Ross JL, Loriaux DL, Cutler GB. J Clin Endocrinol Metab; 1984 Oct; 59(4):801-5. PubMed ID: 6434582 [Abstract] [Full Text] [Related]
10. Effect of deslorelin dose in the treatment of central precocious puberty. Pescovitz OH, Barnes KM, Cutler GB. J Clin Endocrinol Metab; 1991 Jan; 72(1):60-4. PubMed ID: 1898743 [Abstract] [Full Text] [Related]
12. Resumption of puberty after long term luteinizing hormone-releasing hormone agonist treatment of central precocious puberty. Manasco PK, Pescovitz OH, Feuillan PP, Hench KD, Barnes KM, Jones J, Hill SC, Loriaux DL, Cutler GB. J Clin Endocrinol Metab; 1988 Aug; 67(2):368-72. PubMed ID: 3292562 [Abstract] [Full Text] [Related]
13. Serum levels of growth hormone binding protein in children with normal and precocious puberty: relation to age, gender, body composition and gonadal steroids. Juul A, Fisker S, Scheike T, Hertel T, Müller J, Orskov H, Skakkebaek NE. Clin Endocrinol (Oxf); 2000 Feb; 52(2):165-72. PubMed ID: 10671943 [Abstract] [Full Text] [Related]
14. Low growth hormone levels are related to increased body mass index and do not reflect impaired growth in luteinizing hormone-releasing hormone agonist-treated children with precocious puberty. Kamp GA, Manasco PK, Barnes KM, Jones J, Rose SR, Hill SC, Cutler GB. J Clin Endocrinol Metab; 1991 Feb; 72(2):301-7. PubMed ID: 1991801 [Abstract] [Full Text] [Related]
15. Use of a potent, long acting agonist of gonadotropin-releasing hormone in the treatment of precocious puberty. Boepple PA, Mansfield MJ, Wierman ME, Rudlin CR, Bode HH, Crigler JF, Crawford JD, Crowley WF. Endocr Rev; 1986 Feb; 7(1):24-33. PubMed ID: 2937629 [Abstract] [Full Text] [Related]
16. Long-term treatment of central precocious puberty with a long-acting analogue of luteinizing hormone-releasing hormone. Effects on somatic growth and skeletal maturation. Mansfield MJ, Beardsworth DE, Loughlin JS, Crawford JD, Bode HH, Rivier J, Vale W, Kushner DC, Crigler JF, Crowley WF. N Engl J Med; 1983 Nov 24; 309(21):1286-90. PubMed ID: 6415479 [Abstract] [Full Text] [Related]